Your source for all Prime Therapeutics' May 2026 Drug Insights publications.

Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for May 2026 will keep you informed on what’s trending now and trending clinical topics. 

Released May 5, 2026

Watch List

A monthly report of the most notable drugs that may significantly affect the populations we serve. Drug highlights this month are brepocitinib/Riovant, rebisufligene etisparvovec/Ultragenyx and more.

Looking for previous 2026 drug insights publications?

Simply click on the month to access past editions of our drug insights.

January 2026
February 2026
March 2026
April 2026